Pulmonary Hypertension: Common Myths & Misconceptions
Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public or the profession.
Physicians, mid-level providers, nurses and healthcare administrators.
- Recognize clinical conditions that can results in pulmonary hypertension.
- Understand the importance of a methodological workup to eludicate the cause of pulmonary hypertension and guide management.
- Gain insight into specialized therapies that have been developed for the management of WHO group-1 pulmonary arterial hypertension.
WHO group-1 pulmonary arterial hypertenstion (PAH) is a rare but devastating illness. Symptoms are non-specific; and unfortunately, patients are often misdiagnosed with another disorder. A delay in diagnosis and specialized therapies for PAH results in worse prognosis. Increased awareness of PAH is needed.
Sif Hansdottir, MD, PhD
Director, University of Iowa Pulmonary Hypertension Program
- Dr. Hansdottir discloses the following financial relationships with commercial entities: princial investigator for multicenter clinical trials at UIHC for Actelion, Bayer, Gilead, Ikaria, and United Therapeutics.
This program is supported from gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic & First American Bank. The content and selection of a speaker is the responsibility of the Mary Greeley Medical Center Continuing Medical Education Committee and not the Mary Greeley Medical Center Foundation, McFarland Clinic, or First American Bank.
Continuing Education Credit
- DO: Des Moines University is accredited by the American Osteopathic Association (AOA) and approves this live activity for 1.0 Category 2-A CME credit(s).
- 1.00 AOA Category 2A